Indeed, the serum levels of AMH markedly decreased even after ovarian protection with GnRH agonists in our study and a recent study (10) even though both studies presented beneficial effects for preventing chemotherapy-related amenorrhea. This evidence concerns the gene GNRH1 and amenorrhea.